Cargando…
Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m(6)A methylation and increasing the stability of SREBF1 and ChREBP mRNAs
Previous studies have indicated an association of fat mass and obesity-associated (FTO) with nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease worldwide. This study aimed to decipher the complex role of FTO in hepatic lipid metabolism. We found that a decrease in N(6)-m...
Autores principales: | Tang, Zhili, Sun, Chao, Yan, Ying, Niu, Zhoumin, Li, Yuying, Xu, Xi, Zhang, Jing, Wu, Yuting, Li, Yan, Wang, Li, Hu, Cheng, Li, Zhuoyang, Jiang, Jingjing, Ying, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951264/ https://www.ncbi.nlm.nih.gov/pubmed/36352530 http://dx.doi.org/10.1093/jmcb/mjac061 |
Ejemplares similares
-
The structure of importin α and the nuclear localization peptide of ChREBP, and small compound inhibitors of ChREBP–importin α interactions
por: Jung, Hunmin, et al.
Publicado: (2020) -
Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway
por: Zhang, Ying, et al.
Publicado: (2020) -
Carbohydrate Sensing Through the Transcription Factor ChREBP
por: Ortega-Prieto, Paula, et al.
Publicado: (2019) -
Integrated Expression Profiling and Genome-Wide Analysis of ChREBP Targets Reveals the Dual Role for ChREBP in Glucose-Regulated Gene Expression
por: Jeong, Yun-Seung, et al.
Publicado: (2011) -
Islet ChREBP-β is increased in diabetes and controls ChREBP-α and glucose-induced gene expression via a negative feedback loop
por: Jing, Gu, et al.
Publicado: (2016)